uniQure N.V.
N/A
USD
N/A
N/A
...
Chart
Financials
Description
QURE Company Description
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.
QURE Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view QURE Smart Score
Score Breakdown
QURE Company Description
Show More
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of QURE by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by QURE's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
WallStreetBets
Number of mentions of QURE in WallStreetBets Daily Discussion
QURE News
Recent insights relating to QURE
CNBC Recommendations
Recent picks made for QURE stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in QURE
Corporate Flights
Flights by private jets registered to QURE
Our Analysis